Skip to main content
. 2021 Sep 13;22(5):783. doi: 10.3892/ol.2021.13044

Table II.

Incidence of adverse events during treatment period.

Adverse event Any grade, n (%) Grade 3 or 4, n (%)
Anemia 45 (47.9) 13 (13.8)
Neutropenia 71 (75.5) 48 (51.1)
Thrombocytopenia 18 (19.1) 6 (6.4)
Anorexia 20 (21.3) 0 (0.0)
Vomiting 15 (16.0) 0 (0.0)
Nausea 47 (50.0) 0 (0.0)
Diarrhea 16 (17.0) 0 (0.0)
Febrile neutropenia 1 (1.1) 1 (1.1)
Hypertension 12 (12.8) 0 (0.0)
Proteinuria 33 (35.1) 0 (0.0)